KCT0007362招募中未知
Feasibility of CRE8 polymer-free Amphilimus-eluting sTEnt in patients with diffuse long lesions (CREATE trial ): Prospective, Observational study
Yonsei University Yongin Severance Hospital0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1. 19 years of age or older
- •2. Clinical evidence of coronary artery disease including asymptomatic ischemia, stable angina, and acute coronary syndrome (an unstable angina, non-ST segmental ascending myocardial infarction, ST segmental ascending myocardial infarction)
- •3. Coronary lesion length greater than 30 mm
- •4. Voluntary written consent to participate in this clinical study
排除标准
- •1. Life expectancy within one year
- •2. Subjects with known intolerance or contraindications for the following drugs or substances: heparin, aspirin, clopidogrel, prashgrel, ticagreler
- •3. If other researchers decide that they are unsuitable for participation in this study (pregnant women, the elderly, etc.)
研究者
相似试验
进行中（未招募）
不适用
CREATE Trial, Prospective, Observational StudyDrug Eluting StentCoronary Artery DiseaseNCT05658250Yonsei University300
Unknown
3 期
Reservoir-Based Polymer-Free Amphilimus-Eluting Stent Versus Polymer-Based Everolimus-Eluting Stent in Diabetic PatientsDiabetes MellitusCoronary Artery DiseaseNCT01710748Spanish Society of Cardiology112
招募中
不适用
Everolimus-eluting Bioresorbable Scaffolds for Treatment of Coronary Artery Disease in Patients with Diabetes Mellitus.International, Multicenter, Observational, Prospective Registry StudyDiabetes Mellitus, Coronary Artery DiseaseNL-OMON26216Isala Clinics Zwolle500
已完成
不适用
HYBRID SIROLIMUS-ELUTING STENT WITH BIORESORBABLE POLYMER VERSUS EVEROLIMUS-ELUTING STENT WITH DURABABLE POLYMER FOR TOTAL OCCLUSIONS IN NATIVE CORONARY ARTERIES Primary Stenting of Occluded Native Coronary Arteries IV (PRISON IV)stenosis of coronary arteries10011082angina pectorisNL-OMON38171Sint Antonius Ziekenhuis250
进行中（未招募）
不适用
Extracto alergénico despigmentado polimerizado de Dermatophagoides pteronyssinus como tratamiento antiasmático en niños con asma leve alérgicos a ácaros.EUCTR2006-000571-15-ESaboratorios LETI S.L.